Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 078183

Expand all

CIPROFLOXACIN EXTENDED RELEASE (CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE)
212.6MG;EQ 287.5MG BASE
Marketing Status: Discontinued

Active Ingredient: CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
Proprietary Name: CIPROFLOXACIN EXTENDED RELEASE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 212.6MG;EQ 287.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A078183
Product Number: 001
Approval Date: Mar 22, 2007
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CIPROFLOXACIN EXTENDED RELEASE (CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE)
425.2MG;EQ 574.9MG BASE
Marketing Status: Discontinued

Active Ingredient: CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
Proprietary Name: CIPROFLOXACIN EXTENDED RELEASE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 425.2MG;EQ 574.9MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A078183
Product Number: 002
Approval Date: Mar 22, 2007
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information